The long-term prognostic value of E/e’ in patients with ST segment elevation myocardial infarction

Objectives: This study aimed to evaluate the long-term prognostic value of E/e’ ratio in patients with ST-segment elevation myocardial infarction (STEMI). Methods: We retrospectively assessed 314 patients who underwent primary coronary interventions between January 2010 and December 2015. The includ...

Full description

Bibliographic Details
Main Authors: Jino Park, Yeo-Jeong Song, Seunghwan Kim, Dong-Kie Kim, Ki-Hun Kim, Sang-Hoon Seol, Doo-Il Kim, Sang-Jin Ha
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Indian Heart Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0019483222001146
_version_ 1828201237422538752
author Jino Park
Yeo-Jeong Song
Seunghwan Kim
Dong-Kie Kim
Ki-Hun Kim
Sang-Hoon Seol
Doo-Il Kim
Sang-Jin Ha
author_facet Jino Park
Yeo-Jeong Song
Seunghwan Kim
Dong-Kie Kim
Ki-Hun Kim
Sang-Hoon Seol
Doo-Il Kim
Sang-Jin Ha
author_sort Jino Park
collection DOAJ
description Objectives: This study aimed to evaluate the long-term prognostic value of E/e’ ratio in patients with ST-segment elevation myocardial infarction (STEMI). Methods: We retrospectively assessed 314 patients who underwent primary coronary interventions between January 2010 and December 2015. The included patients were classified into two groups according to the E/e’ ratios: E/e’<15 (n = 245) and E/e’≥15 (n = 69). We investigated the incidence of major adverse cardiac events (MACEs) from the event to the final follow-up period of at least three years. Results: A total of 55 cases of MACEs occurred during the follow-up. The E/e’≥15 group showed a significantly higher rate of MACEs than the E/e’<15 group (34.8% vs. 12.7%, p < 0.001). Among the MACE, the percentage of cardiac deaths (17.4% vs. 0.4%, p < 0.001) was higher in the E/e’≥15 group than in the E/e’<15 group. In the multivariable model, E/e’≥15 was demonstrated as the strongest prognostic factor for MACEs (hazard ratio [HR], 2.597; 95% confidence interval [CI], 1.294–5.211; p = 0.007) and cardiac death (HR, 27.537; 95% CI, 3.287–230.689; p = 0.002), while left ventricular ejection fraction (LVEF) was not. Neither the discrepancy of systolic nor diastolic function between initial and follow-up echocardiography affected the overall prevalence of MACEs. A disparity was observed between the two groups, with a significant increase in the rate of MACEs in the E/e’≥15 group (log-rank test, p < 0.001). Conclusion: The baseline E/e’≥15 in patients with STEMI after successful reperfusion is the strongest predictor of poor long-term clinical outcomes among those analyzed.
first_indexed 2024-04-12T11:26:22Z
format Article
id doaj.art-492749baf14a43b683c5eb368b924b99
institution Directory Open Access Journal
issn 0019-4832
language English
last_indexed 2024-04-12T11:26:22Z
publishDate 2022-09-01
publisher Elsevier
record_format Article
series Indian Heart Journal
spelling doaj.art-492749baf14a43b683c5eb368b924b992022-12-22T03:35:13ZengElsevierIndian Heart Journal0019-48322022-09-01745369374The long-term prognostic value of E/e’ in patients with ST segment elevation myocardial infarctionJino Park0Yeo-Jeong Song1Seunghwan Kim2Dong-Kie Kim3Ki-Hun Kim4Sang-Hoon Seol5Doo-Il Kim6Sang-Jin Ha7Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of KoreaDepartment of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea; Corresponding author. Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine 875, Haeun-daero, Haeundae-gu, Busan, 48108, Republic of Korea.Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of KoreaDepartment of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of KoreaDepartment of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of KoreaDepartment of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of KoreaDepartment of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of KoreaDepartment of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Republic of KoreaObjectives: This study aimed to evaluate the long-term prognostic value of E/e’ ratio in patients with ST-segment elevation myocardial infarction (STEMI). Methods: We retrospectively assessed 314 patients who underwent primary coronary interventions between January 2010 and December 2015. The included patients were classified into two groups according to the E/e’ ratios: E/e’<15 (n = 245) and E/e’≥15 (n = 69). We investigated the incidence of major adverse cardiac events (MACEs) from the event to the final follow-up period of at least three years. Results: A total of 55 cases of MACEs occurred during the follow-up. The E/e’≥15 group showed a significantly higher rate of MACEs than the E/e’<15 group (34.8% vs. 12.7%, p < 0.001). Among the MACE, the percentage of cardiac deaths (17.4% vs. 0.4%, p < 0.001) was higher in the E/e’≥15 group than in the E/e’<15 group. In the multivariable model, E/e’≥15 was demonstrated as the strongest prognostic factor for MACEs (hazard ratio [HR], 2.597; 95% confidence interval [CI], 1.294–5.211; p = 0.007) and cardiac death (HR, 27.537; 95% CI, 3.287–230.689; p = 0.002), while left ventricular ejection fraction (LVEF) was not. Neither the discrepancy of systolic nor diastolic function between initial and follow-up echocardiography affected the overall prevalence of MACEs. A disparity was observed between the two groups, with a significant increase in the rate of MACEs in the E/e’≥15 group (log-rank test, p < 0.001). Conclusion: The baseline E/e’≥15 in patients with STEMI after successful reperfusion is the strongest predictor of poor long-term clinical outcomes among those analyzed.http://www.sciencedirect.com/science/article/pii/S0019483222001146E/e’MACEOutcomePrognosisSTEMI
spellingShingle Jino Park
Yeo-Jeong Song
Seunghwan Kim
Dong-Kie Kim
Ki-Hun Kim
Sang-Hoon Seol
Doo-Il Kim
Sang-Jin Ha
The long-term prognostic value of E/e’ in patients with ST segment elevation myocardial infarction
Indian Heart Journal
E/e’
MACE
Outcome
Prognosis
STEMI
title The long-term prognostic value of E/e’ in patients with ST segment elevation myocardial infarction
title_full The long-term prognostic value of E/e’ in patients with ST segment elevation myocardial infarction
title_fullStr The long-term prognostic value of E/e’ in patients with ST segment elevation myocardial infarction
title_full_unstemmed The long-term prognostic value of E/e’ in patients with ST segment elevation myocardial infarction
title_short The long-term prognostic value of E/e’ in patients with ST segment elevation myocardial infarction
title_sort long term prognostic value of e e in patients with st segment elevation myocardial infarction
topic E/e’
MACE
Outcome
Prognosis
STEMI
url http://www.sciencedirect.com/science/article/pii/S0019483222001146
work_keys_str_mv AT jinopark thelongtermprognosticvalueofeeinpatientswithstsegmentelevationmyocardialinfarction
AT yeojeongsong thelongtermprognosticvalueofeeinpatientswithstsegmentelevationmyocardialinfarction
AT seunghwankim thelongtermprognosticvalueofeeinpatientswithstsegmentelevationmyocardialinfarction
AT dongkiekim thelongtermprognosticvalueofeeinpatientswithstsegmentelevationmyocardialinfarction
AT kihunkim thelongtermprognosticvalueofeeinpatientswithstsegmentelevationmyocardialinfarction
AT sanghoonseol thelongtermprognosticvalueofeeinpatientswithstsegmentelevationmyocardialinfarction
AT dooilkim thelongtermprognosticvalueofeeinpatientswithstsegmentelevationmyocardialinfarction
AT sangjinha thelongtermprognosticvalueofeeinpatientswithstsegmentelevationmyocardialinfarction
AT jinopark longtermprognosticvalueofeeinpatientswithstsegmentelevationmyocardialinfarction
AT yeojeongsong longtermprognosticvalueofeeinpatientswithstsegmentelevationmyocardialinfarction
AT seunghwankim longtermprognosticvalueofeeinpatientswithstsegmentelevationmyocardialinfarction
AT dongkiekim longtermprognosticvalueofeeinpatientswithstsegmentelevationmyocardialinfarction
AT kihunkim longtermprognosticvalueofeeinpatientswithstsegmentelevationmyocardialinfarction
AT sanghoonseol longtermprognosticvalueofeeinpatientswithstsegmentelevationmyocardialinfarction
AT dooilkim longtermprognosticvalueofeeinpatientswithstsegmentelevationmyocardialinfarction
AT sangjinha longtermprognosticvalueofeeinpatientswithstsegmentelevationmyocardialinfarction